目的:分析细针吸取细胞学技术在乳腺肿瘤诊断中的临床价值。方法:资料随机选取2013年2月-2014年2月在本院诊治的70例乳腺肿瘤患者,均予细针吸取细胞学技术诊断,对照分析细针吸取细胞学诊断结果与病理组织学结果。结果:细针吸取细胞学技术确诊率91.43%,与病理组织学检验率100%无明显差异;且两种诊断方法中各病情分类无明显差异(P>0.05),结论:细针吸取细胞学技术在乳腺肿瘤诊断中有较高的准确性,可以作为乳腺肿瘤的常规诊断方式,但对疑难病症也存在漏诊及误诊的可能,不能完全代替病理组织学诊断。 Objective: To analyze the clinical value of fine needle aspiration cytology in the diagnosis of breast tumors. Methods: The data were randomly selected from 70 patients with breast cancer diagnosed and treated in our hospital from February 2013 to February 2014. All the patients were diagnosed by fine needle aspiration cytology technique. Fine needle aspiration cytology and histopathological results were compared. Results: The diagnosis rate of fine needle aspiration cytology was 91.43%, which was not significantly different from the pathological examination rate of 100%. There was no significant difference between the two diagnostic methods (P> 0.05). Conclusion: Fine needle aspiration cytology Technology in the diagnosis of breast cancer has a higher accuracy, can be used as a routine diagnostic method for breast cancer, but also difficult to misdiagnosis and misdiagnosis may exist, can not completely replace the histopathological diagnosis.